lipid x has been researched along with Shock, Septic in 5 studies
*Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altobell, LJ; Boyle, NA; Janda, KD; Jones, LH; Lerner, RA; MacDonald, MT; Wentworth, P | 1 |
Danner, RL; Doerfler, ME; Eichacker, PQ; Hoffman, WD; MacVittie, TJ; Natanson, C; Parrillo, JE; Reilly, JM; Stuetz, P; Wilson, J | 1 |
Augy-Dorey, S; Billington, DC; Camara, JA; Gero, SD; Ghezzi, D; Quiclet-Sire, B; Sagnard, I | 1 |
Basalka, E; Lam, C; Schütze, E; Walzl, H | 1 |
Burhop, KE; Proctor, RA; Raetz, CR; Will, JA | 1 |
5 other study(ies) available for lipid x and Shock, Septic
Article | Year |
---|---|
Active immunization with a glycolipid transition state analogue protects against endotoxic shock.
Topics: Animals; Antibodies; Diphosphonates; Escherichia coli; Glycoconjugates; Glycolipids; Hemocyanins; Lipid A; Mice; Molecular Mimicry; Shock, Septic; Tumor Necrosis Factor-alpha; Vaccination; Vaccines, Synthetic | 2002 |
Therapeutic trial of lipid X in a canine model of septic shock.
Topics: Animals; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Escherichia coli; Escherichia coli Infections; Glycolipids; Hemodynamics; Leukocyte Count; Random Allocation; Shock, Septic; Treatment Outcome | 1993 |
Synthesis and biological evaluation of carbocyclic analogues of lipid X: new nonpolar antagonists of LPS induced TNF production.
Topics: Acids, Carbocyclic; Drug Interactions; Glycolipids; Humans; In Vitro Techniques; Lipopolysaccharides; Shock, Septic; Tumor Necrosis Factor-alpha | 1999 |
Protection of mice against lethal endotoxemia by lipid X is mediated through inhibition of neutrophil function.
Topics: Animals; Cell Aggregation; Galactosamine; Glucuronidase; Glycolipids; Humans; In Vitro Techniques; Lipid A; Lipopolysaccharides; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Neutrophils; Shock, Septic; Superoxides | 1987 |
Protection of mice against lethal endotoxemia by a lipid A precursor.
Topics: Animals; Drug Administration Schedule; Endotoxins; Escherichia coli; Glycolipids; Lipid A; Mice; Shock, Septic; Structure-Activity Relationship | 1986 |